In animal models, PXR ablation suppresses HFD-induced obesity, steatosis, and insulin resistance,488 whereas PXR activation recapitulates key features of MASLD and MASH, including steatosis, inflammation, and lipotoxicity.452. This evidence concerns the gene NR1I2 and obesity disorder.